21. Broad‐Scale Monitoring of Tillage Practices Using Sequential Landsat Imagery. Issue 5 (20th September 2013) Authors: Zheng, Baojuan; Campbell, James B.; Shao, Yang; Wynne, Randolph H. Journal: Soil Science Society of America Journal Issue: Volume 77:Issue 5(2013) Page Start: 1755 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial. Issue 2 (10th November 2020) Authors: Chen, Xiaofeng; Wu, Xiaofeng; Wu, Hao; Gu, Yanhong; Shao, Yang; Shao, Qianwen; Zhu, Feipeng; Li, Xiao; Qian, Xiaofeng; Hu, Jun; Zhao, Fengjiao; Mao, Weidong; Sun, Jing; Wang, Jian; Han, Gaohua; Li, Changxian; Xia, Yongxiang; Seesaha, Poshita Kumari; Zhu, Dongqin; Li, Huajun Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial. Issue 2 (10th November 2020) Authors: Chen, Xiaofeng; Wu, Xiaofeng; Wu, Hao; Gu, Yanhong; Shao, Yang; Shao, Qianwen; Zhu, Feipeng; Li, Xiao; Qian, Xiaofeng; Hu, Jun; Zhao, Fengjiao; Mao, Weidong; Sun, Jing; Wang, Jian; Han, Gaohua; Li, Changxian; Xia, Yongxiang; Seesaha, Poshita Kumari; Zhu, Dongqin; Li, Huajun Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial. Issue 2 (10th November 2020) Authors: Chen, Xiaofeng; Wu, Xiaofeng; Wu, Hao; Gu, Yanhong; Shao, Yang; Shao, Qianwen; Zhu, Feipeng; Li, Xiao; Qian, Xiaofeng; Hu, Jun; Zhao, Fengjiao; Mao, Weidong; Sun, Jing; Wang, Jian; Han, Gaohua; Li, Changxian; Xia, Yongxiang; Seesaha, Poshita Kumari; Zhu, Dongqin; Li, Huajun Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial. Issue 2 (10th November 2020) Authors: Chen, Xiaofeng; Wu, Xiaofeng; Wu, Hao; Gu, Yanhong; Shao, Yang; Shao, Qianwen; Zhu, Feipeng; Li, Xiao; Qian, Xiaofeng; Hu, Jun; Zhao, Fengjiao; Mao, Weidong; Sun, Jing; Wang, Jian; Han, Gaohua; Li, Changxian; Xia, Yongxiang; Seesaha, Poshita Kumari; Zhu, Dongqin; Li, Huajun Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial. Issue 2 (10th November 2020) Authors: Chen, Xiaofeng; Wu, Xiaofeng; Wu, Hao; Gu, Yanhong; Shao, Yang; Shao, Qianwen; Zhu, Feipeng; Li, Xiao; Qian, Xiaofeng; Hu, Jun; Zhao, Fengjiao; Mao, Weidong; Sun, Jing; Wang, Jian; Han, Gaohua; Li, Changxian; Xia, Yongxiang; Seesaha, Poshita Kumari; Zhu, Dongqin; Li, Huajun Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial. Issue 2 (10th November 2020) Authors: Chen, Xiaofeng; Wu, Xiaofeng; Wu, Hao; Gu, Yanhong; Shao, Yang; Shao, Qianwen; Zhu, Feipeng; Li, Xiao; Qian, Xiaofeng; Hu, Jun; Zhao, Fengjiao; Mao, Weidong; Sun, Jing; Wang, Jian; Han, Gaohua; Li, Changxian; Xia, Yongxiang; Seesaha, Poshita Kumari; Zhu, Dongqin; Li, Huajun Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Capture‐based next‐generation sequencing reveals multiple actionable mutations in cancer patients failed in traditional testing. Issue 3 (10th January 2016) Authors: Xie, Jing; Lu, Xiongxiong; Wu, Xue; Lin, Xiaoyi; Zhang, Chao; Huang, Xiaofang; Chang, Zhili; Wang, Xinjing; Wen, Chenlei; Tang, Xiaomei; Shi, Minmin; Zhan, Qian; Chen, Hao; Deng, Xiaxing; Peng, Chenghong; Li, Hongwei; Fang, Yuan; Shao, Yang; Shen, Baiyong Journal: Molecular genetics & genomic medicine Issue: Volume 4:Issue 3(2016) Page Start: 262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. Changing of Chinese psychiatrists' attitudes toward consent process to treatment and its association with the China's National Mental Health Law. (January 2019) Authors: Huang, Jingjing; Shao, Yang; Ma, Huajian; Yang, Weimin; Li, Huafang Journal: International journal of psychiatry in medicine Issue: Volume 54:Number 1(2019) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. Cheap, fast and durable degradation of azo dye wastewater by zero-valent iron structural composites. Issue 5 (October 2021) Authors: Si, Jiajia; Yang, Xinglong; Luan, Hengwei; Shao, Yang; Yao, Kefu Journal: Journal of environmental chemical engineering Issue: Volume 9:Issue 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗